Sign In
Buy MDGL
$512.88
+7.13 (+1.41%)
At Close: Jun 22, 2026
Intercept Pharmaceuticals receives FDA Complete Response Letter for treatment for fibrosis due to NASH
11:24am, Monday, 29'th Jun 2020
Intercept Pharmaceuticals Inc. shares undefined tumbled more than 30% in premarket trade Monday, after the company said it has received a U.S. Food and Drug...
Legend Biotech (NASDAQ:PLRX) Reaches New 12-Month High at $32.79
11:10am, Monday, 29'th Jun 2020
Shares of Legend Biotech Corporation (NASDAQ:PLRX) hit a new 52-week high on Monday . The company traded as high as $32.79 and last traded at $32.75, with a volume of 445 shares trading hands. The sto
Durect (DRRX) Gets a Buy Rating from H.C. Wainwright - Markets
10:23am, Monday, 29'th Jun 2020
In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Durect (DRRX – Research Report),
Cowen Initiates Coverage on Legend Biotech (NASDAQ:PLRX)
08:26am, Monday, 29'th Jun 2020
Stock analysts at Cowen began coverage on shares of Legend Biotech (NASDAQ:PLRX) in a research report issued to clients and investors on Monday, BenzingaRatingsTable reports. The brokerage set an “o
Integrating Echosens’ FibroScan into MetaPhy’s Chronic Care Liver Disease Management Program Impacts Patient Outcomes, Costs, Financial Performance
Financial Comparison: GENFIT S A/ADR (GNFT) versus The Competition
02:20am, Sunday, 28'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it contrast to its peers? We will compare GENFIT S A/AD
Should You Avoid Madrigal Pharmaceuticals, Inc. (MDGL)?
02:19am, Sunday, 28'th Jun 2020
In this article you are going to find out whether hedge funds think Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) is a good investment right now. We like to check what the smart money thinks first befo
Inventiva SA Starts U.S. IPO Rollout
03:52pm, Friday, 26'th Jun 2020
Inventiva SA has filed to raise $90 million in a U.S. IPO. The firm is advancing a pipeline of treatment candidates for NASH, MPS and other diseases. IVA is pre
Madrigal Pharmaceuticals (NASDAQ:MDGL) Rating Reiterated by Oppenheimer
01:22am, Friday, 26'th Jun 2020
Madrigal Pharmaceuticals (NASDAQ:MDGL)‘s stock had its “buy” rating restated by stock analysts at Oppenheimer in a research report issued to clients and investors on Wednesday, AnalystRatings.co
GENFIT S A/ADR (GNFT) versus Its Rivals Head to Head Contrast
01:16am, Friday, 26'th Jun 2020
GENFIT S A/ADR (NASDAQ: GNFT) is one of 141 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its rivals? We will compare GENFIT S A/AD
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:00am, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 25)
Brainstorm Cell...
F&O: Nifty50 forms lower lows, but showing a lot of resilience
04:32pm, Thursday, 25'th Jun 2020
India VIX moved up 0.51% from 29.57 to 29.73 level.
Poxel : annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 24 juin 2020 | Zone bourse
03:02pm, Thursday, 25'th Jun 2020What Algernon is doing to potentially combat COVID-19
01:00pm, Thursday, 25'th Jun 2020
Algernon Pharmaceuticals Inc. (CSE: AGN | OTCQB: AGNPF | FSE: AGW) is a clinical stage drug development company focused on the areas of non–alcoholic steatohepatitis (NASH), chronic kidney di…
Tetraphase (TTPH) Gets a Hold Rating from H.C. Wainwright - Markets
10:22am, Thursday, 25'th Jun 2020
H.C. Wainwright analyst Ed Arce maintained a Hold rating on Tetraphase (TTPH – Research Report) today. The company’s shares closed
